Regarding the treatment of osteoporosis, bisphosphonates and recombinant human parathyroid hormone produce their therapeutic effects via either anabolic or anti-resorptive function, with limitation of long-term treatment due to their adverse effects (Kennel and Drake, 2009; Ponnapakkam et al., 2014; Reid, 2015). Here, PTH is linked to osteoporosis.